Algonquin Power & Utilities Corp. Price Target Cut to $6.50
An analyst firm has lowered the price target for Algonquin Power & Utilities Corp. to $6.50 per share.
Stocks · News reference
Algonquin Power & Utilities Corp. Completes Sale of Ownership Stake in Chilean Utility
Algonquin Power & Utilities Corp. has finalized the sale of its approximately 64% interest in the Chilean water utility Suralis S.A. to a fund managed by Toesca S.A. Administradora General de Fondos.
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- fiscal.ai
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
Algonquin Power & Utilities (AQN) Q3 Earnings and Revenues Beat Estimates
Algonquin Power & Utilities reported Q3 2026 earnings of $0.11 per share, beating consensus estimates of $0.10, with revenues of $642.5 million exceeding expectations by 1.98%. However, the company received a Zacks Rank #4 (Sell) rating due to unfavorable estimate revision trends ahead of the earnings release. The stock has underperformed the market, declining 8.3% year-to-date versus the S&P 500's 7.4% gain.
Algonquin Power & Utilities Declares Quarterly Dividend
Algonquin Power & Utilities Corp. has declared a quarterly dividend of $0.065 per share.
Algonquin Power & Utilities Corp. Declares Dividend for RT RESET PFD-D Shares
Algonquin Power & Utilities Corp. announced a quarterly dividend for its RT RESET PFD-D preferred shares.
Algonquin Power & Utilities Corp. Reports Third Quarter 2026 Financial Results
Algonquin Power & Utilities Corp. announced its financial results for the third quarter of 2026, reporting net earnings of $57.6 million.
Enbridge, Moderna On Deck Friday As Demand, Vaccine Pipeline Face Test
Enbridge headlines Friday’s reports, with investors weighing whether resilient pipeline utilization can offset a softer revenue comparison. Moderna, Brookfield Asset Management, Humana, Vistra, PPL, Plains All American